Canada reminded the biotech industry last week that governments have the last word when it comes to mergers. The Canadian minister of industry, Brian Tobin, did not meet a March 30 deadline to approve the proposed $4 billion stock acquisition of BioChem Pharma Inc. by Shire Pharmaceuticals Group plc, noting that